ImClone Systems (Nasdaq: IMCL) Chairman Carl Icahn sent the following letter to Bristol-Myers (NYSE: BMY) after a raised $62 offer.
This article: 211 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE